SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Neogen Chemicals informs about outcome of board meeting

31 May 2021 Evaluate

In compliance with the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 (‘Listing Regulations’), Neogen Chemicals has informed that the Board of Directors of the Company had at its meeting held on 29th May 2021, considered and approved the following: Approved the Audited Financial Results (Standalone and Consolidated) of the Company along with the Audit Reports for the Quarter and Financial Year ended March 31, 2021, pursuant to Regulation 33 of the Listing Regulations, which has been duly reviewed and recommended by the Audit Committee; Pursuant to Regulation 33(3) (d) of the Listing Regulations, the company has declared that the Statutory Auditors of the Company JMT & Associates, Chartered Accountants (FRN: 104167W) have issued the Auditors Report on Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Financial Year ended March 31, 2021 with un-modified opinion and a declaration to that effect is enclosed, Recommended a final dividend of Rs 2.25 per Equity Share for the Financial Year 2020-21, subject to approval of Shareholders at the ensuing Annual General Meeting of the Company and Constitution of the Risk Management Committee of the Company. The Board Meeting commenced at 7.00 pm and concluded at 10.00 pm. The Audited Financial Results are also being uploaded on the Company’s Website at www.neogenchem.com.

The above information is a part of company’s filings submitted to BSE.

Neogen Chemicals Share Price

1509.30 1.45 (0.10%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
BASF India 3703.10
Tata Chemicals 709.05
SRF 2493.65
Pidilite Inds. 1393.25
Deepak Nitrite 1538.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×